Epidermal ADAM17 is dispensable for notch activation

Journal of Investigative Dermatology

Volumn 133, Issue 9, 2013, Pages 2286-2288

  Groot, Arjan J ^a   Cobzaru, Cristina ^b   Weber, Silvio ^c   Saftig, Paul ^d   Blobel, Carl P ^e   Kopan, Raphael ^f   Vooijs, Marc ^a   Franzke, Claus Werner ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e HOSPITAL FOR SPECIAL SURGERY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL; CROSS LINKING; DERMATITIS; HUMAN; IN VITRO STUDY; KERATINOCYTE; LETTER; MOLECULAR WEIGHT; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; TISSUE CULTURE CELL; UPREGULATION;

EID: 84884415915     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.162     Document Type: Letter

References (15)

1. Blobel CP (2005) ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6:32-43
2. Bozkulak EC, Weinmaster G (2009) Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol Cell Biol 29: 5679-95
3. de Guzman Strong C, Wertz PW, Wang C et al. (2006) Lipid defect underlies selective skin barrier impairment of an epidermalspecific deletion of Gata-3. J Cell Biol 175: 661-70
4. Demehri S, Liu Z, Lee J et al. (2008) Notchdeficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, asentinel for epidermal integrity. PLoS Biol 6:e123
5. Dumortier A, Durham AD, Di Piazza M et al. (2010) Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS One 5:e9258
6. Franzke CW, Cobzaru C, Triantafyllopoulou A et al. (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209: 1105-19
7. Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137:216-33
8. Kuhn PH, Wang H, Dislich B et al. (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29:3020-32
9. Miettinen PJ, Berger JE, Meneses J et al. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-41
10. Murthy A, Shao YW, Narala SR et al. (2012) Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36: 105-19
11. Peschon JJ, Slack JL, Reddy P et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281-4
12. Rand MD, Grimm LM, Artavanis-Tsakonas S et al. (2000) Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 20:1825-35
13. van Tetering G, van Diest P, Verlaan I et al. (2009) Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem 284:31018-27
14. van Tetering G, Vooijs M (2011) Proteolytic cleavage of Notch: 'HIT and RUN'. Curr Mol Med 11:255-69
15. Weber S, Niessen MT, Prox J et al. (2011) The disintegrin/ metalloproteinase Adam10 is essential for epidermal integrity and Notchmediated signaling. Development 138: 495-505